CtrlK
Novo Integrated Sciences
NVOS48
$0.14arrow_drop_down11.32%-$0.01
Penny Stock
NVOS48
$0.14
arrow_drop_down11.32%Performance History
There's no data available for performance history chart
| Key Stats | |
|---|---|
| Open | $0.18 |
| Prev. Close | $0.17 |
| EPS | -1.33 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $1.15M |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 0.11 | 0.18 |
| 52 Week Range | 0.11 | 3.45 |
| Ratios | |
|---|---|
| P/B Ratio | 0.12 |
| Revenue | - |
| Operating M. % | -30.39% |
| Earnings | $0.00 |
| Earnings Growth % | - |
| EBITDA Margin % | -45.53% |
| ROE % | -82.47% |
| EPS | -1.33 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Predicted: 23 seconds ago
info
Analyzed by 6 Wall Street experts, Moleculin Biotech 's 12-month projections average at $16.33, spanning from a high of $40.00 to a low of $3.00. This signifies an 1,291.25% shift from the current price of $1.16.
Analyst Ratings
Buy
| Buy | 2 | 66.67% | |
|---|---|---|---|
| Hold | 1 | 33.33% | |
| Sell | 0 | 0.00% |
•Ratings from: March•
Last updated: 23 seconds ago
•Total: 3info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.
About Novo Integrated Sciences (NVOS)
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- CEO
- Mr. Robert Mattacchione
- Headquarters
- Bellevue
- Employees
- 115
- Exchange
- NASDAQ
Keep an eye on Novo Integrated Sciences
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Novo Integrated Sciences's (NVOS) price per share?
The current price per share for Novo Integrated Sciences (NVOS) is $0.15. The stock has seen a price change of -$0.02 recently, indicating a -11.33% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Novo Integrated Sciences (NVOS)?
For Novo Integrated Sciences (NVOS), the 52-week high is $3.45, which is 2.22K% from the current price. The 52-week low is $0.11, the current price is 35.45% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Novo Integrated Sciences (NVOS) a growth stock?
Novo Integrated Sciences (NVOS) has shown an average price growth of -1.65% over the past three years. It has received a score of 81 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Novo Integrated Sciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Novo Integrated Sciences (NVOS) stock price performance year to date (YTD)?
As of the latest data, Novo Integrated Sciences (NVOS) has a year-to-date price change of 187.09%. Over the past month, the stock has experienced a price change of 161.63%. Over the last three months, the change has been 247.32%. Over the past six months, the figure is -50.95%.
help
Is Novo Integrated Sciences (NVOS) a profitable company?
Novo Integrated Sciences (NVOS) has a net income of -$13.27M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 43.2% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -30.39% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 5.75%, providing insight into the company's sales performance and growth. The gross profit is $5.74M. Operating income is noted at -$10.08M. Furthermore, the EBITDA is -$6.05M.
help
What is the market capitalization of Novo Integrated Sciences (NVOS)?
Novo Integrated Sciences (NVOS) has a market capitalization of $1.16M. The average daily trading volume is 0.15, indicating the stock's liquidity and investor engagement.